In-Depth Partners’s Idexx Laboratories IDXX Stock Holding History

In-Depth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,488	Closed	-$1.46M	–	13
2025 Q1	$1.46M	Sell	3,488 -4,710	-57%	-$2.05M	1.68%	12
2024 Q4	$3.39M	Hold	8,198	–	–	3.59%	10
2024 Q3	$4.14M	Sell	8,198 -4,287	-34%	-$2.08M	4.3%	12
2024 Q2	$6.08M	Sell	12,485 -2,769	-18%	-$1.39M	5.6%	9
2024 Q1	$8.24M	Buy	15,254 +410	+3%	+$224K	6.47%	9
2023 Q4	$8.24M	Hold	14,844	–	–	7.2%	8
2023 Q3	$6.49M	Buy	14,844 +1,696	+13%	+$846K	6.12%	9
2023 Q2	$6.6M	Buy	13,148 +1,214	+10%	+$582K	6.91%	8
2023 Q1	$5.97M	Buy	11,934 +2,125	+22%	+$1.02M	7.26%	9
2022 Q4	$4M	Hold	9,809	–	–	7.3%	8
2022 Q3	$3.2M	Buy	9,809 +532	+6%	+$195K	5.64%	9
2022 Q2	$3.25M	Sell	9,277 -3,436	-27%	-$1.4M	5.94%	9
2022 Q1	$6.96M	Sell	12,713 -2,874	-18%	-$1.51M	6.81%	8
2021 Q4	$10.3M	Buy	+15,587	New	+$9.78M	6.23%	9

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

In-Depth Partners's IDXX Position: Q2 2025 in Review

In-Depth Partners sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 3,488 shares — an estimated $1.46M sold.

In-Depth Partners first reported a position in IDXX in Q4 2021 and held it in 14 quarters. The position peaked at $10.3M in Q4 2021. 1,235 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

In-Depth Partners reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
In-Depth Partners sold 3,488 Idexx Laboratories shares in Q2 2025, an estimated $1.46M.
In-Depth Partners first reported a position in Idexx Laboratories in Q4 2021 and held it in 14 quarters.
In-Depth Partners's Idexx Laboratories position peaked at $10.3M in Q4 2021.
1,235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on In-Depth Partners's 13F filing for Q2 2025, filed 14 Aug 2025.